We also cannot determine if the PSA prior to the prostate cancer diagnosis was ordered for screening or diagnostic purpose, and the CDW does not include post-diagnosis prostate cancer clinical stage or grade information to identify men with more advanced disease at a given PSA. This evidence concerns the gene KLK3 and prostate carcinoma.